We combine oncology expertise with advanced technology and analytics to organize real world data in order to guide decisions and actions.
Together, we can bring clarity to cancer care.
We curate EHR data that can be used to drive research and standardization in order to improve patient outcomes while also reducing costs at your institution.
We make clinical sense of claims data, providing insight into performance and related outcomes across sites in order to support value-based payment models.
Our deeply curated real world data accelerates drug development informing the decisions and actions that will deliver the best drugs to patients faster and at a lower cost.
All data companies working in the healthcare industry are on a mission to help with the development of drugs and high-quality treatments while aiming for the best patient outcomes.
But, unlike controlled conditions under which clinical trials are conducted, real world data is collected from a variety of different sources. It is an unregulated but critical area of clinical research. That’s why many conversations around the standardization of this type of data have occupied data scientists’ attention. The FDA has recently released a document with guidance on how to use real world data for regulatory submissions.
COTA announced findings from a study that found 66% of cancer patients and families surveyed think the speed of clinical trials for cancer treatments remains far too slow. Read more of the findings from the study, which surveyed 1,110 Americans who’ve either had cancer or who’ve had someone in their immediate family with cancer.
Let’s work together to transform cancer care.
